Food And Drug Administration

Fda Approves First Generics Of Lyrica

July 22, 2019 -- On July 19, the U.S. Food and Drug Administration approved multiple applications for first generics of Lyrica (pregabalin) for the management of neuropathic pain associated with diabetic peripheral neuropathy, for the management...
Related topics: Diabetes

Read More →

Fda Targets Teens With E-cigarette Prevention Ads

Today, the FDA launched its first e-cigarette prevention TV ads. Part of "The Real Cost" campaign, they're meant to educate teens on the dangers of e-cigarette use. The ads will target nearly 10.7 million teens, aged 12 to 17, who...

Read More →

Keep Sugar Substitute Away From Fido

SUNDAY, July 21, 2019 -- The sugar substitute xylitol may help you lose weight, but it can be deadly for your dog, the U.S. Food and Drug Administration warns. Xylitol is present in many human foods and other products, and the FDA's Center for...

Read More →

America’s Unsafe Medical Products

So far in July, the U.S. Food and Drug Administration has issued safety alerts on 11 devices and medicines used by consumers and health care providers. All but one of those alerts has been a product...

Read More →

Don't Hold Your Breath For The Fda's Cbd Report

Whether you realize it or not, this is going to be a big year for the North American cannabis industry. Sure, history was made in 2018 with Canada launching recreational cannabis sales in licensed dispensaries, and the U.S. Food and Drug...

Read More →

Fda Warns That ‘big Penis’ Supplement Works A Little Too Well

The FDA is one of the more vital government agencies when it comes to keeping consumers safe from deceptive marketing and dangerous products, but sometimes a product comes along that we can assume is trash even before the FDA weighs in. In any case,...
Related topics: Marketing

Read More →

Fda Clears Low-level Laser Device For 'whole Body' Pain

The FDA has granted marketing clearance for a low-level laser device for the treatment of "whole body" musculoskeletal pain, the manufacturer has announced. FDA Approvals
Related topics: Marketing

Read More →

Merck's Antibiotic Recarbrio Gets Fda Nod For Infections

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Merck & Co., Inc. (MRK): Free Stock Analysis Report Sanofi (SNY): Free Stock Analysis...
Related topics: Merck & Co, Antibiotics, Medical Research, Sanofi

Read More →

No Fracture Risk For New Diabetes Drugs In Real-world Study

Link between SGLT2 inhibitors for type 2 diabetes and fractures has been controversial. Canagliflozin has an FDA warning about the risk, but some studies have found no link. Medscape Medical News
Related topics: Diabetes, Type 2 Diabetes, Medical Research

Read More →

Fda Approves Drug Trio For Uti, Intra-abdominal Infection

The FDA approved the antibacterial drug trio imipenem, cilastatin, and relebactam for adults with complicated urinary tract infections and complicated intra-abdominal infections. FDA Approvals

Read More →

This Ai Breast Cancer Diagnostic Tool Is The First To Get Fda Clearance

Paragon Biosciences and Qlarity Imaging LLC are using artificial intelligence to improve breast cancer diagnosis. There are few things in life more frightening than a possible cancer diagnosis. Now the machines are here to help. Paragon Biosciences...
Related topics: Breast Cancer, Cancer, Oncology

Read More →

Hackers Made An App That Kills To Prove A Point

Medtronic and the FDA left an insulin pump with a potentially deadly vulnerability on the market—until researchers who found the flaw showed how bad it could be.
Related topics: Medtronic, Insulin, Medical Research

Read More →

Two Senators With Business Degrees Want The Fda To Tell Doctors They Should Not Treat Chronic Pain...

Sen. Joe Manchin (D-W.V.) has a bachelor's degree in business administration. Sen. Mike Braun (R-Ind.) has an MBA from Harvard. Yet the two senators seem to think they have the medical expertise to second-guess the judgment of physicians across the...
Related topics: Chronic Pain, Harvard University

Read More →

Ats Celebrates Court-established Deadlines For E-cigarettes And Cigars Regulation

Last Friday afternoon, July 12, 2019, a federal court decision established deadlines for e-cigarette manufacturers and makers of candy-flavored cigars to submit their products for FDA review. The Court took this action after medical and public...

Read More →

Ats Celebrates Court-established Deadlines For E-cigarettes And Cigars Regulation

Last Friday afternoon, July 12, 2019, a federal court decision established deadlines for e-cigarette manufacturers and makers of candy-flavored cigars to submit their products for FDA review. The Court took this action after medical and public...

Read More →

'fighting The Wrong War': Chronic Pain Patients Push Feds To Change Opioid Policies

The FDA, CDC and HHS are examining policies on opioid prescribing as chronic pain patients who need prescriptions to function were left in agony.       
Related topics: Chronic Pain, Centers For Disease Control And Prevention

Read More →

What’s So Great About Hookipa Pharma’s Hpv Cancer Treatment

Hookipa Pharma is not a household name, or even well-known within the biotech industry, but it is making waves on Friday after the firm announced an update from the FDA.
Related topics: Cancer, Oncology

Read More →

Fda Accepts Neurocrine's Nda For Parkinson's Disease Drug

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AbbVie Inc. (ABBV): Free Stock Analysis Report Acorda Therapeutics, Inc. (ACOR): Free...
Related topics: Parkinson's, Medical Research

Read More →

Novel Therapy For Acute Migraine Shows Promise In Phase 3 Clinical Trial

A drug belonging to a new generation of acute migraine headache treatments was found to eliminate pain and reduce bothersome symptoms for people with migraine in a large-scale trial. The drug, rimegepant, is awaiting US Food and Drug Administration...
Related topics: Migraine, Clinical Trials

Read More →

Xpovio With Dexamethasone Approved For Refractory Multiple Myeloma

TUESDAY, July 9, 2019 -- Xpovio (selinexor) tablets have been approved for use in combination with dexamethasone to treat adults with relapsed refractory multiple myeloma, the U.S. Food and Drug Administration announced last week. The drug...

Read More →
What is noozilla?
Noozilla is an independent news aggregation service with a categorization engine that categorizes millions of news stories by subject.